Advertisement
UK markets closed
  • NIKKEI 225

    39,667.07
    +493.92 (+1.26%)
     
  • HANG SENG

    18,089.93
    +17.03 (+0.09%)
     
  • CRUDE OIL

    81.38
    +0.55 (+0.68%)
     
  • GOLD FUTURES

    2,312.70
    -18.10 (-0.78%)
     
  • DOW

    39,148.37
    +36.21 (+0.09%)
     
  • Bitcoin GBP

    48,461.30
    -324.08 (-0.66%)
     
  • CMC Crypto 200

    1,263.30
    -20.48 (-1.59%)
     
  • NASDAQ Composite

    17,751.01
    +33.35 (+0.19%)
     
  • UK FTSE All Share

    4,480.66
    -12.41 (-0.28%)
     

Ionis to present at TD Cowen Genetic Medicines & RNA Summit

CARLSBAD, Calif., June 17, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a fireside chat at the virtual TD Cowen Genetic Medicines & RNA Summit on Thursday, June 20, 2024.

Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)
Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

A live webcast of this presentation can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

ADVERTISEMENT

To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – ir@ionis.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffermedia@ionis.com – 760-603-4679

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-td-cowen-genetic-medicines--rna-summit-302174669.html

SOURCE Ionis Pharmaceuticals, Inc.